Hepatocellular Carcinoma: Fighting the Rising Tide

Jemal A. , Siegel R. , Ward E. . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4): 225–249.

GLOBOCAN 2002. International Agency for Research in Cancer. Lyon, France. http://www-dep.iarc.fr/GLOBOCAN_frame.htm. Accessed March 3, 2010.

Bruix J. , Llovet J.M. . Hepatitis B virus and hepatocellular carcinoma. J Hepatol. 2003; 39(suppl 1): S59–S63.

Kuper H. , Ye W. , Broomé U. . The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology. 2001; 34(4 Pt 1): 714–718.

Chuang S.C. , La Vecchia C. , Boffetta P. . Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009; 286(1): 9–14.

Kornberg A. , Küpper B. , Thrum K. . Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patients. Transplant Proc. 2009; 41(6): 2561–2563.

Llovet J.M. , Ricci S. , Mazzaferro V. . Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359(4): 378–390.